Gift Nifty higher; Brent, WTI and US futures point mixed
Gift Nifty points to a firmer open. Brent and WTI are softer, while DXY is higher. Nifty options show PCR at 0.9364, max pain at 23,300 and spot at 23,217.6.
Why the tape looks like this
Gift Nifty at 23,267.00 (+0.30%) — firm open signalled
S&P closed −0.45%, Nikkei +0.07% — that's the overnight handoff Indian futures are pricing.
Options pin the tape at 23,300
PCR 0.94 (call-writer edge), spot 23,217.60. Writers own 23,000–24,000.
Brent $105.42 (−0.39%) · USD/INR 95.94
Softer crude eases the import bill and OMC marketing margins.
Global Cues
Overnight contextIndia VIX 13.17
Options Board
2026-09-22 expiryPCR
0.94
call-writer edge
Max Pain
23,300
Spot
23,217.60
Put Wall
23,000
support
Call Wall
24,000
resistance
Open interest by strike
as of 15:44 ISTKey Developments
Overnight & pre-openSensex today | Stock Market Highlights: Sensex gains 333 points, Nifty rises 99 points; FMCG, PSU banks outperform
Why it matters — Sensex, Nifty, Share Prices Highlights: Indian equity markets ended higher on Wednesday, tracking gains across regional
Sensex today | Stock Market Live: Domestic market to open on flat to negative note as US Fed talks hawkish, NSE IPO in focus
Why it matters — Sensex, Nifty, Share Prices LIVE: Indian equities are likely to open on negative note today amid mixed global cues. GIFT
Stock Market LIVE: GIFT Nifty signals negative open; Asia mkts mixed post US Fed's rate hike
Why it matters — Sensex Today | Stock Market LIVE Updates Thursday: The GIFT Nifty indicated a slightly lower open for the Nifty50. Asian
Nifty may slip to 22,500; 3 technical stock ideas for today by Jatin Gedia
Nifty 50's structure remains weak; PVR INOX among top picks: Ajit Mishra
Why it matters — Nifty's recovery above the 23,200 level provides some near-term relief; however, the broader structure remains weak.
Gold slips as Fed hike, hawkish outlook strengthen dollar
Holtec Nuclear postpones U.S. IPO, citing market conditions
Day Ahead
Results · macro · corporate actionsMacro & corporate actions
23Educational market commentary only. Not SEBI-registered investment advice.